01 Jan Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals
Posted at 00:00h
in
Authored by: Vermeulen Joost N., Prins Jan M., Bunnik Evelien, Hack C. Erik, Jurriaans Suzanne, Miedema Frank, Lange Joep M. A., Schuitemaker Hanneke
In: AIDS RESEARCH AND HUMAN RETROVIRUSES 23(11), 2007, p.1348-1353
http://www.ncbi.nlm.nih.gov/pubmed/18184076